Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells

The fusion between anaplastic lymphoma kinase (ALK) and echinoderm microtubule-associated protein-like 4 (EML4) is a causative factor in a unique subset of patients with non-small cell lung carcinoma (NSCLC). Although the inhibitor crizotinib, as it blocks the kinase activity of the resulting EML4-A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Oh, Se Jin, Noh, Kyung Hee, Lee, Young-Ho, Hong, Soon-Oh, Song, Kwon-Ho, Lee, Hyo-Jung, Kim, Soyeon, Kim, Tae Min, Jeon, Ju-Hong, Seo, Jae Hong, Kim, Dong-Wan, Kim, Tae Woo
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741893/
https://ncbi.nlm.nih.gov/pubmed/26517679
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados